LPL Financial’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-45,000
Closed -$140K 6056
2025
Q4
$140K Sell
45,000
-5,000
-10% -$14.3K ﹤0.01% 5542
2025
Q3
$132K Buy
50,000
+15,000
+43% +$33.1K ﹤0.01% 5448
2025
Q2
$43K Buy
+35,000
New +$38.2K ﹤0.01% 5379

Other funds holding GOSS

LPL Financial's GOSS Position: Q1 2026 in Review

LPL Financial increased its Gossamer Bio (GOSS) stake by 3.6% in Q1 2026, buying an estimated $20.1K and bringing the position to 371,734 shares worth $122K. The position accounts for ﹤0.01% of the portfolio, ranked #5632.

LPL Financial first reported a position in GOSS in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.11M in Q4 2025. 184 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • LPL Financial held 371,734 shares of Gossamer Bio worth $122K as of Q1 2026.
  • LPL Financial bought 12,817 Gossamer Bio shares in Q1 2026, an estimated $20.1K.
  • Gossamer Bio made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #5632 holding.
  • LPL Financial first reported a position in Gossamer Bio in Q2 2025 and has held it in 4 quarters since.
  • LPL Financial's Gossamer Bio position peaked at $1.11M in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.